Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low Grade Neoplasms: A Case with a Highly Increased Proliferation Rate
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F24%3AN0000014" target="_blank" >RIV/27283933:_____/24:N0000014 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00023001:_____/24:00084917
Výsledek na webu
<a href="https://pubmed.ncbi.nlm.nih.gov/38403790/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/38403790/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12022-024-09802-7" target="_blank" >10.1007/s12022-024-09802-7</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low Grade Neoplasms: A Case with a Highly Increased Proliferation Rate
Popis výsledku v původním jazyce
Traditionally considered non-functional low proliferative benign neuroendocrine proliferations measuring less than 5 mm, pancreatic (neuro)endocrine microadenomas are now classifed as pancreatic neuroendocrine microtumors in the 2022 WHO classifcation of endocrine and neuroendocrine tumors. This case report discussed the features of an incidentally identifed 4.7-mm glucagon-expressing pancreatic neuroendocrine microtumor with MEN1 mutation only, chromosomally stable and an epigenetic alpha-like phenotype. The tumor was associated with an unexplained increased proliferation rate in Ki-67 of 15%. There was no associated DAXX/ATRX defciency. The presented case challenges the conventional thought of a low proliferative disease of the so-called “pancreatic neuroendocrine microadenomas” and provides additional support to the 2022 WHO classifcation that also requires grading of these neoplasms. Despite exhibiting molecular features of less aggressive behavior, the case also underscores the biological complexity of pancreatic neuroendocrine microtumors. By recognizing the heterogenous spectrum of neuroendocrine neoplasms, the current case also contributes to ongoing discussions on how to optimize the clinical management of such tumors.
Název v anglickém jazyce
Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low Grade Neoplasms: A Case with a Highly Increased Proliferation Rate
Popis výsledku anglicky
Traditionally considered non-functional low proliferative benign neuroendocrine proliferations measuring less than 5 mm, pancreatic (neuro)endocrine microadenomas are now classifed as pancreatic neuroendocrine microtumors in the 2022 WHO classifcation of endocrine and neuroendocrine tumors. This case report discussed the features of an incidentally identifed 4.7-mm glucagon-expressing pancreatic neuroendocrine microtumor with MEN1 mutation only, chromosomally stable and an epigenetic alpha-like phenotype. The tumor was associated with an unexplained increased proliferation rate in Ki-67 of 15%. There was no associated DAXX/ATRX defciency. The presented case challenges the conventional thought of a low proliferative disease of the so-called “pancreatic neuroendocrine microadenomas” and provides additional support to the 2022 WHO classifcation that also requires grading of these neoplasms. Despite exhibiting molecular features of less aggressive behavior, the case also underscores the biological complexity of pancreatic neuroendocrine microtumors. By recognizing the heterogenous spectrum of neuroendocrine neoplasms, the current case also contributes to ongoing discussions on how to optimize the clinical management of such tumors.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30109 - Pathology
Návaznosti výsledku
Projekt
—
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Endocrine Pathology
ISSN
1046-3976
e-ISSN
1559-0097
Svazek periodika
35
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
8
Strana od-do
147-153
Kód UT WoS článku
001170279400001
EID výsledku v databázi Scopus
2-s2.0-85185972541